Maximize Returns with AI-Powered REGN Insights

AI REGN Forecast

Price Forecast:

Bearish <-> Bullish

Bullish Case: Increased demand for Dupixent and Eylea bolstered by recent FDA approvals may drive Regeneron's revenues higher, supported by positive analyst targets enhancing investor sentiment.

Bearish Case: Regeneron faces legal challenges and competitive pressures, particularly with Eylea's biosimilars, which could significantly impact future revenues and stock performance.

Potential Outcomes:

1. FDA approval or positive news on drug pipelines: 60%

2. Successful settlement of legal issues leading to stabilizing stock: 25%

3. Increased competition hurts stock performance: 15%

Trading Oracle: Sign Up to access trading oracle trade ideas.

October 01, 2024

Regeneron Pharmaceuticals Forecast

REGN Regeneron Pharmaceuticals

Price Forecast
Future Uncertainty

4 Day Price Forecast + Historical Performance. Video Tutorial: Trade Smarter With Helium's AI Forecasts

9 Day Price Forecast + Historical Performance. Video Tutorial: Trade Smarter With Helium's AI Forecasts

20 Day Price Forecast + Historical Performance. Video Tutorial: Trade Smarter With Helium's AI Forecasts

36 Day Price Forecast + Historical Performance. Video Tutorial: Trade Smarter With Helium's AI Forecasts

49 Day Price Forecast + Historical Performance. Video Tutorial: Trade Smarter With Helium's AI Forecasts

See Longer Forecasts

Correlated Assets

Assets that tend to move strongly with REGN

TJX TJX Companies (0.97)

ISRG Intuitive Surgical (0.97)

GLW Corning (0.96)

VIG Vanguard Group, Inc. - Vanguard Dividend Appreciation FTF (0.96)

GWRE Guidewire Software (0.96)

Uncorrelated Assets

Assets with little price relationship to REGN

NXE NexGen Energy (-0.0)

CPA Copa (0.01)

ILMN Illumina (0.01)

MTCH Match (0.01)

NEOG Neogen (-0.01)

Anticorrelated Assets

Assets that tend to move strongly against REGN

SDOW ProShares UltraPro Short Dow30 (-0.93)

SH ProShares Short S&P500 (-0.95)

SDS ProShares UltraShort S&P500 (-0.95)

SPXS Direxion Daily S&P 500 Bear 3X Shares (-0.95)

LABD Direxion Daily S&P Biotech Bear 3X Shares (-0.95)

Become a more profitable investor with AI optimized trading strategies

Market Forecasts

Bullish / Bearish

Digital Assets / Most Accurate

Trading Strategies

Long Volatility

Short Volatility

Balanced News

Balanced News / Sources

Tech / Memes / Politics

About

About / Pricing / Forum

Contact Helium Trades

2024 © Helium Trades
Privacy Policy & Disclosure

* Disclaimer: Nothing on this website constitutes investment advice, performance data or any recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Helium Trades is not responsible in any way for the accuracy of any model predictions or price data. Any mention of a particular security and related prediction data is not a recommendation to buy or sell that security. Investments in securities involve the risk of loss. Past performance is no guarantee of future results. Helium Trades is not responsible for any of your investment decisions, you should consult a financial expert before engaging in any transaction.